****Duke nasal-swab olfactory test + EvON digital therapy early AD signal [developing]**** [developing]
Key Questions
What is the Duke nasal swab test for early Alzheimer's detection?
Duke's nasal swab olfactory test assesses microglia LC pruning in n=22 pre-symptomatic individuals with 81% accuracy. It detects early smell loss as a PS flip warning sign.
How does smell loss signal early Alzheimer's?
Loss of smell is an early warning sign of Alzheimer’s, linked to olfactory changes preceding symptoms. The Duke study confirms its pre-symptomatic predictive value.
What is EvON digital therapy and its results in MCI?
EvON's RCT in n=70 MCI patients showed PACC+2.34 improvement, earning FDA breakthrough designation. It complements non-invasive tools like nasal swabs alongside blood p-tau screening.
Duke nasal swab olfactory microglia LC pruning n=22 81% acc pre-symp validated PET; smell loss PS flip early warning; EvON RCT n=70 MCI PACC+2.34 FDA BT; nasal EVs spray inflammaging. Replication/non-invasive complements blood p-tau screening.